SCHEMBL1823288

SCHEMBL1823288

Cc1ccc(S(=O)(=O)Oc2cccc(C(CC(=O)OC(C)(C)C)C(N)C(=O)OCC3c4ccccc4-c4ccccc43)c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
DHODH Q02127 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CASP3 P42574 2/20 0.32
GPR17 Q13304 1/20 0.32
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
G6PD P11413 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
DRD2 P14416 1/20 0.31
DRD1 P21728 1/20 0.31
DRD4 P21917 1/20 0.31
DRD5 P21918 1/20 0.31
DRD3 P35462 1/20 0.31
MAOB P27338 1/20 0.31
BACE1 P56817 1/20 0.31
EPHX2 P34913 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824795 0.94 CASP3 (0.36) CASP3BACE1EPHX2KMT2A
SCHEMBL1825016 0.91 DHODH (0.35) DHODHALDH1A1CASP3GPR17GAA
SCHEMBL1822423 0.91 CASP3 (0.35) DHODHALDH1A1CASP3GPR17GAA
SCHEMBL1824353 0.91 P2RX7 (0.37) P2RX7ABCG2DHODHALDH1A1CASP3
SCHEMBL1821706 0.90 GPR17 (0.34) DHODHALDH1A1CASP3GPR17GAA
SCHEMBL1826700 0.89 P2RX7 (0.36) P2RX7ABCG2DHODHALDH1A1CASP3
SCHEMBL1823965 0.89 CASP3 (0.36) CASP3BACE1EPHX2KMT2A
SCHEMBL1824997 0.88 LMNA (0.38) P2RX7DHODHCASP3MAPTKMT2A
SCHEMBL1824919 0.87 GPR17 (0.38) P2RX7ABCG2DHODHALDH1A1GPR17
SCHEMBL1824970 0.86 CASP3 (0.37) ALDH1A1CASP3EPHX2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 P2RX7 3606/4885ABCG2 550/4885DHODH 2965/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 P2RX7 2747/4885ABCG2 136/4885DHODH 1171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.